Inventurus Knowledge Solutions IPO

Inventurus Knowledge Solutions Ltd

₹13,915 /11 sharesMinimum Investment

Inventurus Knowledge Solutions IPO Details

Bidding DatesMin. InvestmentLot SizePrice Range
12 Dec ‘24 - 16 Dec ‘24₹13,91511₹1,265 - ₹1,329
Issue SizeIPO Doc
2497.92Cr
RHP PDF

Subscription rate

As of 12 Dec'24, 06:00 PM
Qualified Institutional Buyers1.54431734741564x
Non-Institutional Investor0.787092429605036x
Retail Individual Investor1.67934918982408x
Employees0.803676923076923x
Total1.36x

About Inventurus Knowledge Solutions

Inventurus Knowledge Solutions (IKS) is a technology-focused provider of healthcare solutions, offering a care enablement platform. The company serves physician enterprises primarily in the United States, as well as in Canada and Australia. IKS supports both outpatient and inpatient care providers. The company’s platform is designed to cater to outpatient services, which encompass medical treatments such as observation, consultations, diagnoses, rehabilitation, interventions, and treatments—all provided without requiring hospital admission. Additionally, IKS addresses the needs of inpatient care, where patients receive medical attention that necessitates an overnight stay or extended hospitalisation.;
Founded in
2006
Managing director
Mr. Berjis Minoo Desai
Parent organisation
Inventurus Knowledge Solutions Ltd

Strengths & Financials of Inventurus Knowledge Solutions

Strengths
Risks
As of September 30, 2024, IKS served 778 healthcare organisations, including health systems, academic medical centres, multi-speciality and single-speciality medical groups, ancillary healthcare providers, and various outpatient and inpatient care organisations.
IKS' client base includes notable organisations such as Atlanta Women’s Health Group, Boston Children’s Health Physicians, Hanger Inc., US Digestive Health (GI MSO Inc.), Lehigh Valley Health Network, Lightbeam Health Solutions, Mass General Brigham, MRPG, Professional Occupational and Physical Therapy, Sema4, Spear Physical Therapy, Texas Health Care PLLC, The GI Alliance Management, Duke Health, McLaren, Maxim Health Services, Providence, and Thundermist Health Centre.
IKS offers a digital health platform designed to help clients optimise their technology systems. Its Unifying Data Platform (UDP) enables the integration of data from multiple sources, including billing systems, electronic health records (EHRs), and clearinghouses, into a centralised database. This eliminates the need for EHR or billing system migrations and reduces capital expenditure, providing clients with streamlined access to actionable insights for effective decision-making.
With the acquisition of Aquity Holdings on October 27, 2023, IKS expanded its capabilities in clinical documentation, medical coding, and revenue integrity solutions. This acquisition allows IKS to cross-sell its solutions to Aquity’s existing customer base of over 804 healthcare organisations (as of March 31, 2024), significantly broadening its market opportunities.
IKS delivers innovative proprietary platforms that enhance healthcare operations: like IKS EVE (a multi-channel patient access and engagement solution.), Optimix (a workflow management platform focused on revenue optimisation), IKS Stacks (a platform that uses OCR, NLP, and proprietary algorithms to extract data from clinical documents), IKS AssuRx (a prescription renewal processing engine that aggregates and handles requests seamlessly), and IKS Scribble (a solution combining automation, AI, and human expertise to create medical notes for physicians).
IKS states that the company leverages RPA to automate repetitive and structured tasks within virtual environments. This includes routine payer interactions, claims rebilling, eligibility inquiries, and claim status tracking through payer websites. These automated processes increase efficiency and reduce operational burdens for healthcare organisations.
The company has seen a consistent increase in revenue from operations and profit after tax (PAT). Revenue from operations increased from Rs 763.63 crore in FY22 to Rs 1,031.3 crore in FY23 to Rs 1,817.93 crore in FY24. PAT increased from Rs 232.97 crore in FY22, to Rs 305.23 crore in FY23 to Rs 370.49 crore in FY24.

Inventurus Knowledge Solutions Financials

*All values are in Rs. Cr
No Graph Data To Display

Application Details of Inventurus Knowledge Solutions IPO

Apply asPrice bandApply upto
Regular1265 - 1329₹2 Lakh
Employee1265 - 1329₹2 Lakh
High Networth Individual1265 - 1329₹2 - 5 Lakh
For Inventurus Knowledge Solutions IPO, eligible investors can apply as Regular & Employee.
ⓒ 2016-2024 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 5.5.9
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  GROWWMF |  SBI |  AXIS |  HDFC |  UTI |  NIPPON INDIA |  ICICI PRUDENTIAL |  TATA |  KOTAK |  DSP |  CANARA ROBECO |  SUNDARAM |  MIRAE ASSET |  IDFC |  FRANKLIN TEMPLETON |  PPFAS |  MOTILAL OSWAL |  INVESCO |  EDELWEISS |  ADITYA BIRLA SUN LIFE |  LIC |  HSBC |  NAVI |  QUANTUM |  UNION |  ITI |  MAHINDRA MANULIFE |  360 ONE |  BOI |  TAURUS |  JM FINANCIAL |  PGIM |  SHRIRAM |  BARODA BNP PARIBAS |  QUANT |  WHITEOAK CAPITAL |  TRUST |  SAMCO |  NJ

ABOUT GROWW